September 22, 2023

Taylor Daily Press

Complete News World

WHO approves eighth corona vaccine: India’s cofaxine “very suitable for low- and middle-income countries” |  Corona virus what you need to know

WHO approves eighth corona vaccine: India’s cofaxine “very suitable for low- and middle-income countries” | Corona virus what you need to know

The World Health Organization has given emergency approval to the Covaxin corona vaccine, developed by Indian pharmaceutical company Bharat Biotech. The World Health Organization stated this in a press release. It is the eighth vaccine for corona that gets the green light from the World Health Organization.

As part of the EUL’s procedure for granting emergency approval (Emergency Use List), the World Health Organization is investigating the quality, safety and efficacy of coronavirus vaccines. Without this approval, the vaccine cannot be included in the Covax program, which provides vaccines to poor countries. Countries can also use information from the World Health Organization to more quickly approve vaccines for the use of their citizens. Vaccines from Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson have already been given the go-ahead, as well as vaccines from Chinese manufacturers Sinovac Biotech and Sinopharm.

Covaxin vaccine is based on inactivated SARS-CoV-2 antigen. The WHO expert group recommends that adults be given the vaccine in two doses four weeks apart. Research shows the vaccine is 78 percent effective against Covid. It is also very suitable for use in low and middle income countries because it is easy to store.

“This emergency approval expands the availability of vaccines, which are the most effective medical tools we have to end the pandemic,” said WHO Deputy Director-General Mariangela Simao. “However, we must continue to increase pressure to meet the needs of the entire population. We must prioritize those at risk who are still waiting for their first dose before we can declare victory.”

See also  look. A security problem at Schiphol Airport? The former employee explains how he still got in: 'I could have pulled all the plugs out of the plane' | outside

billion pricks

India started its vaccination campaign early this year. Residents will be vaccinated for free with Covaxin, Covishield developed by AstraZeneca and the University of Oxford, and the Russian Sputnik-V vaccine. So far, more than a billion shots have been taken.

Approval means good news for Indians traveling. Australia and Oman have already said they recognize Covaxin as a valid vaccine. The same is expected to apply to the United States. Countries such as Iran and Brazil also use Covaxin.

Five long-term scenarios for another path of the Corona epidemic: from “flu +” to “the worst is yet to come”(+)

Read all about the corona virus at our profile.